1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis.

Title1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis.
Publication TypeJournal Article
Year of Publication2013
AuthorsLuo J, Wen H, Guo H, Cai Q, Li S, Li X
JournalBioMed research international
Volume2013
Pagination101805
Date Published2013
Abstract

To study effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) on RANKL signaling pathway and pathway-associated cytokines in patients with rheumatoid arthritis (RA).

DOI10.1155/2013/101805
Alternate JournalBiomed Res Int